PRAC concludes assessment of gadolinium agents used in body scans and recommends regulatory actions, including suspension for some marketing authorisations
13.03.2017
more
13.03.2017
more
13.03.2017
more
13.03.2017
more
03.03.2017
more
02.03.2017
more
28.02.2017
more
28.02.2017
more
21.02.2017
more
03.02.2017
more
01.02.2017
more